Example: Heart Attack

Clinical Trials on Wells Syndrome

Total 49 results

NCT00465985

Completed

Efficacy, Safety, and Tolerability of ACZ885 in Patients With Muckle-Wells Syndrome

Conditions: Muckle Wells Syndrome
NCT01045772

Completed

Safety and Tolerability of Rilonacept in Muckle-Wells Syndrome (MWS) or Schnitzler Syndrome (SchS)

Conditions: Muckle-Wells Syndrome; Schnitzler Syndrome
NCT01211977

Withdrawn

A Pilot Study of XOMA 052 in Familial Cold Autoinflammatory Syndrome / Muckle-Wells Syndrome and Behcet's Disease

Conditions: Muckle Wells Syndrome; Autoinflammatory; Behcet's Disease
NCT00685373

Completed

Efficacy and Safety of ACZ885 in Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease

Conditions: Cryopyrin-Associated Periodic Syndromes; Familial Cold Autoinflammatory Syndrome; Muckle Wells Syndrome; Neonatal Onset Multisystem Inflammatory Disease
NCT01576367

Completed

Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease

Conditions: Cryopyrin-associated Periodic Syndromes; Familial Cold Autoinflammatory Syndrome; Muckle-Wells Syndrome; Neonatal Onset Multisystem Inflammatory Disease
NCT01302860

Completed

Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease

Conditions: Cryopyrin-associated Periodic Syndromes; Familial Cold Autoinflammatory Syndrome; Muckle-Wells Syndrome; Neonatal Onset Multisystem Inflammatory Disease
NCT00991146

Completed

Efficacy and Safety Study of Canakinumab Administered for 6 Months (24 Weeks) in Japanese Patients With Cryopyrin-associated Periodic Syndromes Followed by an Extension Phase

Conditions: Cryopyrin-associated Periodic Syndromes; Familial Cold Autoinflammatory Syndrome; Muckle-Wells Syndrome; Neonatal Onset Multisystem Inflammatory Disease
NCT00288704

Completed

Rilonacept for Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS)

Conditions: Familial Cold Autoinflammatory Syndrome (FCAS); Familial Cold Urticaria; Muckle-Wells Syndrome (MWS); Genetic Diseases, Inborn
NCT00487708

Completed

Safety, Efficacy, Pharmacokinetics, Pharmacodynamics of ACZ885 in Patients With NALP3 Mutations and Clinical Symptoms

Conditions: NALP3 Mutation
NCT00094900

Completed

Interleukin-1 Trap to Treat Autoinflammatory Diseases

Conditions: Inflammation; Familial Mediterranean Fever; Still's Disease, Adult-Onset
NCT01213641

Completed

Clinical Outcomes and Safety: A Registry Study of Ilaris (Canakinumab) Patients

Conditions: Cryopyrin-associated Periodic Syndromes (CAPS); Familial Cold Autoinflam Syn (FCAS); Muckle-wells Syn (MWS); Neonatal Onset Multisystem Inflam Disease (NOMID)
NCT02853084

Terminated

HL2351 CAPS Phase II Study

Conditions: Cryopyrin-Associated Periodic Syndromes (CAPS)
NCT01105507

Completed

The Safety and Efficacy of Canakinumab in Patients Aged 4 Years or Older Diagnosed With Cryopyrin-associated Periodic Syndromes (CAPS) in Canada

Conditions: Cryopyrin Associated Periodic Syndrome
NCT02334748

Completed

A Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis or Hereditary Periodic Fevers Who Participated in the CACZ885G2301E1, CACZ885G2306 or CACZ885N2301 Studies

Conditions: Systemic Juvenile Idiopathic Arthritis; Hereditary Periodic Fevers
NCT03338868

Unknown status

Serum Concentrations, Physical and Psychological Well-being in Metabolic Syndrome

Conditions: Metabolic Syndrome
NCT01848483

Completed

Living Well Project for Persons With AIDS

Conditions: Acquired Immunodeficiency Syndrome (AIDS)
NCT03453489

Unknown status

AMT-PET in Monitoring Telotristat Etiprate Treatment in Participants With Metastatic Well Differentiated Neuroendocrine Neoplasm

Conditions: Carcinoid Syndrome; Metastatic Nonfunctional Well Differentiated Neuroendocrine Neoplasm
NCT04065165

Withdrawn

Lanreotide Combined With Telotristat Ethyl or Placebo for the First-line Treatment in Patients With Advanced Well Differentiated Small Intestinal Neuroendocrine Tumours (siNET) With Highly-functioning Carcinoid Syndrome

Conditions: Small Intestinal NET; Carcinoid Heart Disease
NCT03245034

Completed

Assessing the Impact of Acupuncture Therapy on Medical Resident Well-Being: Feasibility and Acceptance

Conditions: Exhaustion; Syndrome
NCT03571256

Completed

A Study to Test if TEV-50717 is Effective in Relieving Tics Associated With Tourette Syndrome (TS)

Conditions: Tourette Syndrome
NCT02343211

Completed

Immunotherapy and Paraneoplastic Neurological Syndromes

Conditions: Paraneoplastic Neurological Syndromes
NCT04641325

Recruiting

Marfan Syndrome Moderate Exercise Pilot

Conditions: Marfan Syndrome
NCT04435899

Completed

Exercise Mediation on Hormonal, Immune and Psychological Well-being in Institutionalized Frail Older Women.

Conditions: Frail Elderly Syndrome
NCT00391924

Completed

Dehydroepiandrosterone Administration in Women With Systemic Lupus Erythematosus or Primary Sjögren's Syndrome

Conditions: Lupus Erythematosus, Systemic; Sjogren's Syndrome
NCT02649933

Terminated

Detection of Sleep Apnea Syndrome (OSA) in Pregnant Women and Assessment of Impact of OSA on Pregnancy Course

Conditions: Pregnancy; Sleep Apnea Syndrome; Obstructive Sleep Apnea